Literature DB >> 14506914

Protease inhibitors: synthesis of bacterial collagenase and matrix metalloproteinase inhibitors incorporating succinyl hydroxamate and iminodiacetic acid hydroxamate moieties.

M Amélia Santos1, Sérgio Marques, Marco Gil, Matteo Tegoni, Andrea Scozzafava, Claudiu T Supuran.   

Abstract

A series of succinyl hydroxamates/bishydroxamates as well as a new structural type of matrix metalloproteinase (MMP)/bacterial protease (BP) inhibitors, incorporating iminodiacetic (IDA) hydroxamate/bishydroxamate moieties, has been synthesized and tested for interaction with four vertebrate proteases, MMP-1, MMP-2, MMP-8 and MMP-9, and a BP, the collagenase isolated from Clostridium histolyticum (ChC). The new derivatives generally showed inhibition constants in the range of 8-62 nM against the five proteases mentioned above.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14506914     DOI: 10.1080/1475636031000081134

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  3 in total

1.  NAHA, a novel hydroxamic acid-derivative, inhibits growth and angiogenesis of breast cancer in vitro and in vivo.

Authors:  Jiahua Jiang; Anita Thyagarajan-Sahu; Viktor Krchňák; Andrej Jedinak; George E Sandusky; Daniel Sliva
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

2.  Discovery of a Potent Inhibitor Class with High Selectivity toward Clostridial Collagenases.

Authors:  Esther Schönauer; Andreas M Kany; Jörg Haupenthal; Kristina Hüsecken; Isabel J Hoppe; Katrin Voos; Samir Yahiaoui; Brigitta Elsässer; Christian Ducho; Hans Brandstetter; Rolf W Hartmann
Journal:  J Am Chem Soc       Date:  2017-08-31       Impact factor: 15.419

3.  Phosphonate as a Stable Zinc-Binding Group for "Pathoblocker" Inhibitors of Clostridial Collagenase H (ColH).

Authors:  Katrin Voos; Esther Schönauer; Alaa Alhayek; Jörg Haupenthal; Anastasia Andreas; Rolf Müller; Rolf W Hartmann; Hans Brandstetter; Anna K H Hirsch; Christian Ducho
Journal:  ChemMedChem       Date:  2021-03-16       Impact factor: 3.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.